Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Director departure
Quarterly results
Appointed COO
Appointed director

HUMANIGEN, INC (HGEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/04/2021 8-K Investor presentation
Docs: "Lenzilumab Treatment May Provide Enhanced Likelihood of Survival Without Ventilation in Hospitalized Black and African-American COVID-19 Patients",
"Humanigen Presentation “LIVE-AIR Phase 3 Study Update: Highest Response Rates Observed in Black and African-American Patients” dated August 2021"
01/11/2021 8-K Quarterly results
08/10/2020 8-K Quarterly results
06/16/2020 8-K Investor presentation
Docs: "Stakeholder presentation materials delivered June 16, 2020"
08/21/2018 8-K Investor presentation
Docs: "Investor Presentation"
06/05/2018 8-K Quarterly results
01/29/2018 8-K Investor presentation
Docs: "Investor Presentation"
04/20/2017 8-K Form 8-K - Current report
02/15/2017 8-K Form 8-K - Current report
10/14/2016 8-K Investor presentation
Docs: "Investor Presentation"
12/03/2015 8-K Investor presentation
Docs: "Corporate Presentation"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy